Article
SARS-CoV-2 Exploits Sexually Dimorphic and Adaptive IFN and TNFa Signaling to Gain Entry…
medRxiv · 2021 · Giancotti, F.; Wang, Y.; Gurrapu, S.; Chen, H.; Laudato, S.; Caggiano, E.; Jiang, Y.; Ling, H.-H.
Key facts
| Title | SARS-CoV-2 Exploits Sexually Dimorphic and Adaptive IFN and TNFa Signaling to Gain Entry into Alveolar Epithelium |
|---|---|
| First author | Giancotti, F.; Wang, Y.; Gurrapu, S.; Chen, H.; Laudato, S.; Caggiano, E.; Jiang, Y.; Ling, H.-H. |
| Journal | medRxiv |
| Published | Jul 24, 2021 |
| DOI | 10.1101/2021.07.23.453505 |
| Devices mentioned | BK110039, K042152, K103302, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, NDS, PCA, KIP, KIT, NJT, OOI, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1